Multisystem comorbidities and shared genetic pathways in calcific aortic stenosis: a phenome-wide and Mendelian

Zihao Zhou1, Yidan Zheng1, Shiyan Hu1

  • 1Department of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.

PubMed

Insights

Calcific aortic stenosis (CAS) is linked to many systemic conditions, primarily due to genetic factors involving LPA and lipoprotein(a). Targeting LPA may reduce the broad health burden of CAS.

Area of Science:

  • Cardiovascular Medicine
  • Genetics
  • Epidemiology

Background:

  • Calcific aortic stenosis (CAS) often co-occurs with systemic diseases, but their links and genetic basis are unclear.
  • Understanding these relationships is crucial for managing CAS patients comprehensively.

Purpose of the Study:

  • To map the network of CAS comorbidities across multiple body systems.
  • To identify shared genetic mechanisms underlying CAS and its associated conditions.

Main Methods:

  • Utilized UK Biobank data (467,484 participants) for observational and polygenic phenome-wide association studies.
  • Employed disease-trajectory analyses and two-sample Mendelian randomization (MR) with FinnGen data.
  • Assessed the role of LPA variants and plasma lipoprotein(a) (Lp(a)) using polygenic risk score (PRS) analyses.

Main Results:

  • CAS showed associations with 42 cardiovascular and non-cardiovascular conditions, notably metabolic, endocrine, hematologic, and respiratory disorders.
  • Circulatory and metabolic diseases often preceded other comorbidities in CAS trajectories.
  • MR supported causal links from CAS to cardiovascular diseases, iron-deficiency anemia, mental disorders, and pleural effusion, largely mediated by LPA/Lp(a).

Conclusions:

  • CAS is part of a wide multisystem comorbidity network, significantly influenced by genetic variation at LPA and elevated Lp(a).
  • These findings reveal pleiotropic effects linking valvular calcification to systemic diseases.
  • Targeting LPA presents a potential therapeutic strategy to alleviate the systemic burden of CAS.
Abstract

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
15.2K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
846
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
336
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.8K
Epistasis Analysis01:09

Epistasis Analysis

Although Mendel chose seven unrelated traits in peas to study gene segregation, most traits involve multiple gene interactions that create a spectrum of phenotypes. When the interaction of various genes or alleles at different locations influences a phenotype, this is called epistasis. Epistasis often involves one gene masking or interfering with the expression of another (antagonistic epistasis). Epistasis often occurs when different genes are part of the same biochemical pathway. The...
5.6K
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
384